Zhejiang Yatai Pharmaceutical Co., Ltd. (002370.SZ)
CNY 3.02
(0.33%)
CNY 3.02
(0.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 420.64 Million | 373.44 Million | 315.13 Million | 514.88 Million | 709.29 Million | 1.13 Billion |
| Cost of Revenue | 288.54 Million | 239.83 Million | 195.75 Million | 251.29 Million | 455.36 Million | 626.29 Million |
| Gross Profit | 132.09 Million | 133.6 Million | 119.37 Million | 263.59 Million | 253.92 Million | 506.09 Million |
| Operating Expenses | 161.03 Million | 142.77 Million | 242.35 Million | 322.2 Million | 374.48 Million | 307.88 Million |
| Selling, General and Administrative Expenses | 93.88 Million | 82.86 Million | 155.01 Million | 219.64 Million | 220.69 Million | 176.22 Million |
| Research and Development Expenses | 21.79 Million | 26.13 Million | 28.61 Million | 37.34 Million | 70.09 Million | 57.2 Million |
| Other Expenses | 51.88 Million | 33.76 Million | 58.72 Million | 65.21 Million | 83.68 Million | 28 Thousand |
| Cost and Expenses | 446.68 Million | 382.6 Million | 438.1 Million | 573.5 Million | 829.84 Million | 934.18 Million |
| Operating Income | -63.45 Million | -16.17 Million | -122.97 Million | -58.61 Million | -120.55 Million | 174.52 Million |
| Interest Expense | 47.47 Million | 52.31 Million | 56.87 Million | 68.07 Million | 57.56 Million | 15.07 Million |
| Income Tax Expense | 313.28 Thousand | -2.59 Million | 4.11 Million | 1.12 Million | -312.07 Thousand | 22.02 Million |
| Earnings before Tax | -11.56 Million | -135.31 Million | -224.16 Million | 28.39 Million | -1.92 Billion | 174.55 Million |
| Net Income | -11.87 Million | -132.72 Million | -228.28 Million | 27.27 Million | -1.92 Billion | 150.94 Million |
| Earnings Per Share Basic | -0.02 | -0.25 | -0.43 | 0.05 | -3.58 | 0.28 |
| Earnings Per Share Diluted | -0.02 | -0.25 | -0.43 | 0.05 | -3.58 | 0.28 |
| Weighted Average Shares Outstanding | 593.84 Million | 536.68 Million | 536.61 Million | 536.55 Million | 536.5 Million | 532.78 Million |
| Weighted Average Shares Outstanding (Diluted) | 593.84 Million | 536.68 Million | 536.61 Million | 536.55 Million | 536.5 Million | 539.09 Million |
| Gross Margin | 0.31 | 0.36 | 0.38 | 0.51 | 0.36 | 0.45 |
| EBIT Margin | 0.18 | 0.07 | -0.28 | -0.04 | -1.68 | 0.22 |
| Profit Margin | -0.03 | -0.36 | -0.72 | 0.05 | -2.71 | 0.13 |
| EBITDA | 76.31 Million | 25.44 Million | -121.63 Million | 147.85 Million | -1.77 Billion | 308.19 Million |
| Earnings Before Tax Margin | -0.15 | -0.04 | -0.39 | -0.11 | -0.17 | 0.15 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 83.21 Million | 107.47 Million | 111.49 Million | 420.64 Million | 118.78 Million | 80.72 Million |
| Cost of Revenue | 60.15 Million | 78.05 Million | 75.87 Million | 285.64 Million | 85.72 Million | 58.43 Million |
| Gross Profit | 23.06 Million | 29.42 Million | 35.61 Million | 134.99 Million | 33.05 Million | 22.28 Million |
| Operating Expenses | 32.89 Million | 28.8 Million | 32.62 Million | 161.03 Million | 37.95 Million | 36.41 Million |
| Selling, General and Administrative Expenses | 29.78 Million | 26.42 Million | 27.11 Million | - | -11.51 Million | 52.23 Million |
| Research and Development Expenses | 3.1 Million | 1.37 Million | 4.64 Million | - | 5.89 Million | 7.87 Million |
| Other Expenses | - | -994.81 Thousand | -872.54 Thousand | 51.88 Million | 803.85 Thousand | 25.2 Thousand |
| Cost and Expenses | 93.04 Million | 106.85 Million | 108.5 Million | 446.68 Million | 123.68 Million | 94.84 Million |
| Operating Income | -9.82 Million | 618.26 Thousand | 2.99 Million | -63.45 Million | -14.16 Million | -18 Million |
| Interest Expense | 8.4 Million | 9.03 Million | 8.92 Million | 47.45 Million | 9.32 Million | 11.74 Million |
| Income Tax Expense | 571.71 Thousand | -205.77 Thousand | -209.05 Thousand | 313.28 Thousand | -220.1 Thousand | 527.79 Thousand |
| Earnings before Tax | -8.36 Million | -5.59 Million | -3.2 Million | -11.56 Million | -13.35 Million | -17.97 Million |
| Net Income | -8.93 Million | 8.47 Million | -2.99 Million | -11.87 Million | -13.13 Million | -18.5 Million |
| Earnings Per Share Basic | -0.01 | 0.01 | -0.00 | - | -0.02 | -0.03 |
| Earnings Per Share Diluted | -0.01 | 0.01 | -0.00 | - | -0.02 | -0.03 |
| Weighted Average Shares Outstanding | 612.47 Million | 609.17 Million | 609.17 Million | 593.84 Million | 589.11 Million | 564.21 Million |
| Weighted Average Shares Outstanding (Diluted) | 612.47 Million | 609.17 Million | 609.17 Million | 593.84 Million | 589.11 Million | 564.21 Million |
| Gross Margin | 0.28 | 0.27 | 0.32 | 0.32 | 0.28 | 0.28 |
| EBIT Margin | 0.00 | 0.10 | 0.07 | - | -0.01 | -0.12 |
| Profit Margin | -0.11 | 0.08 | -0.03 | -0.03 | -0.11 | -0.23 |
| EBITDA | 44.09 Thousand | 10.21 Million | 7.58 Million | - | -790.12 Thousand | -9.57 Million |
| Earnings Before Tax Margin | -0.12 | 0.01 | 0.03 | -0.15 | -0.12 | -0.22 |
0M0Q
HQL
SOFTSOL
LQAG
PRG
ALTPC